Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
FPI-2068 by Fusion Pharmaceuticals for Metastatic Colorectal Cancer: Likelihood of Approval
FPI-2068 is under clinical development by Fusion Pharmaceuticals and currently in Phase I for Metastatic Colorectal Cancer. According to GlobalData,...
FPI-2068 by Fusion Pharmaceuticals for Recurrent Head And Neck Squamous Cell Carcinoma: Likelihood of Approval
FPI-2068 is under clinical development by Fusion Pharmaceuticals and currently in Phase I for Recurrent Head And Neck Squamous Cell...
FPI-2068 by Fusion Pharmaceuticals for Solid Tumor: Likelihood of Approval
FPI-2068 is under clinical development by Fusion Pharmaceuticals and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
FPI-2068 by Fusion Pharmaceuticals for Non-Small Cell Lung Cancer: Likelihood of Approval
FPI-2068 is under clinical development by Fusion Pharmaceuticals and currently in Phase I for Non-Small Cell Lung Cancer. According to...